메뉴 건너뛰기




Volumn 31, Issue 4, 2011, Pages 521-523

Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy

(2)  Bes, Cemal a   Soy, Mehmet a  

a NONE

Author keywords

Leflunomide; SLE; Tjalma syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; CA 125 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DEFLAZACORT; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE;

EID: 79954449459     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1190-2     Document Type: Article
Times cited : (20)

References (15)
  • 1
    • 0000464842 scopus 로고
    • Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax
    • 13154792 1:STN:280:DyaG2c%2FnsVOntA%3D%3D
    • JV Meigs 1954 Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax Obstet Gynecol 3 471 486 13154792 1:STN:280: DyaG2c%2FnsVOntA%3D%3D
    • (1954) Obstet Gynecol , vol.3 , pp. 471-486
    • Meigs, J.V.1
  • 2
    • 0029048806 scopus 로고
    • Pseudo-Meigs' syndrome and lupus
    • 7649329 10.1016/0020-7292(95)02355-G 1:STN:280:DyaK2MznslCrtw%3D%3D
    • EA Widra J Armstrong 1995 Pseudo-Meigs' syndrome and lupus Int J Gynaecol Obstet 49 2 193 194 7649329 10.1016/0020-7292(95)02355-G 1:STN:280: DyaK2MznslCrtw%3D%3D
    • (1995) Int J Gynaecol Obstet , vol.49 , Issue.2 , pp. 193-194
    • Widra, E.A.1    Armstrong, J.2
  • 3
    • 15544378399 scopus 로고    scopus 로고
    • Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome
    • DOI 10.1016/j.ygyno.2004.12.022
    • WA Tjalma 2005 Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome Gynecol Oncol 97 1 288 291 15790480 10.1016/j.ygyno.2004. 12.022 (Pubitemid 40403716)
    • (2005) Gynecologic Oncology , vol.97 , Issue.1 , pp. 288-291
    • Tjalma, W.A.A.1
  • 4
    • 32644468938 scopus 로고    scopus 로고
    • Tjalma's syndrome [10]
    • DOI 10.1016/S0140-6736(06)68220-2, PII S0140673606682202
    • WA Tjalma 2006 Tjalma's syndrome Lancet 367 9510 567 568 16488797 10.1016/S0140-6736(06)68220-2 (Pubitemid 43247567)
    • (2006) Lancet , vol.367 , Issue.9510 , pp. 567-568
    • Tjalma, W.A.A.1
  • 5
    • 27644589137 scopus 로고    scopus 로고
    • Pseudo-pseudo Meigs' syndrome
    • DOI 10.1016/S0140-6736(05)67666-0, PII S0140673605676660
    • R Schmitt W Weichert W Schneider FC Luft R Kettritz 2005 Pseudo-pseudo Meigs' syndrome Lancet 366 9497 1672 16271650 10.1016/S0140-6736(05)67666-0 (Pubitemid 41552424)
    • (2005) Lancet , vol.366 , Issue.9497 , pp. 1672
    • Schmitt, R.1    Weichert, W.2    Schneider, W.3    Luft, F.C.4    Kettritz, R.5
  • 6
    • 42249115506 scopus 로고    scopus 로고
    • Tjalma's or pseudo-pseudo-Meigs' syndrome: A case report
    • DOI 10.1111/j.1365-2230.2007.02665.x
    • UM Ural A Kiliç T Güngör B Özdal L Mollamahmutoglu 2008 Tjalma's or pseudo-pseudo-Meigs' syndrome: a case report Clin Exp Dermatol 33 3 363 364 18419611 10.1111/j.1365-2230.2007.02665.x 1:STN:280: DC%2BD1c3lvFCrug%3D%3D (Pubitemid 351550649)
    • (2008) Clinical and Experimental Dermatology , vol.33 , Issue.3 , pp. 363-364
    • Ural, U.M.1    Kilic, A.2    Gungor, T.3    Ozdal, B.4    Mollamahmutoglu, L.5
  • 7
    • 0033781432 scopus 로고    scopus 로고
    • Meigs syndrome and bfalse positiveQ preoperative serum CA-125 levels: Analysis of ten cases
    • 11055482 1:STN:280:DC%2BD3crgsVyjsw%3D%3D
    • B Patsner 2000 Meigs syndrome and bfalse positiveQ preoperative serum CA-125 levels: analysis of ten cases Eur J Gynaecol Oncol 21 362 363 11055482 1:STN:280:DC%2BD3crgsVyjsw%3D%3D
    • (2000) Eur J Gynaecol Oncol , vol.21 , pp. 362-363
    • Patsner, B.1
  • 8
    • 0036224253 scopus 로고    scopus 로고
    • The role of inflammatory cytokines in Meigs' syndrome
    • DOI 10.1016/S0029-7844(01)01602-7, PII S0029784401016027
    • Y Abramov SO Anteby SJ Fasouliotis V Barak 2002 The role of inflammatory cytokines in Meigs' syndrome Obstet Gynecol 99 917 919 11975958 10.1016/S0029-7844(01)01602-7 1:CAS:528:DC%2BD38XjtVSjsLc%3D (Pubitemid 34442419)
    • (2002) Obstetrics and Gynecology , vol.99 , Issue.5 SUPPL. 1 , pp. 917-919
    • Abramov, Y.1    Anteby, S.O.2    Fasouliotis, S.J.3    Barak, V.4
  • 9
    • 0036314278 scopus 로고    scopus 로고
    • Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus
    • DOI 10.1191/0961203302lu199oa
    • E Robak A Wozniacka A Sysa-Jedrejowska H Stepien T Robak 2002 Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus Lupus 11 6 348 355 12139372 10.1191/0961203302lu199oa 1:CAS:528:DC%2BD38XlvFyrt7g%3D (Pubitemid 34760632)
    • (2002) Lupus , vol.11 , Issue.6 , pp. 348-355
    • Robak, E.1    Wozniacka, A.2    Sysa-Jedrzejowska, A.3    Stepien, H.4    Robak, T.5
  • 10
    • 0031865023 scopus 로고    scopus 로고
    • Mechanism of action of leflunomide in rheumatoid arthritis
    • RI Fox 1998 Mechanism of action of leflunomide in rheumatoid arthritis J Rheumatol Suppl 53 20 26 9666414 1:CAS:528:DyaK1cXks1Kjuro%3D (Pubitemid 28335318)
    • (1998) Journal of Rheumatology , vol.25 , Issue.SUPPL. 53 , pp. 20-26
    • Fox, R.I.1
  • 11
    • 0034925128 scopus 로고    scopus 로고
    • Benefits of leflunomide in systemic lupus erythematosus: A pilot observational study
    • DOI 10.1191/096120301678416033
    • CF Remer MH Weisman DJ Wallace 2001 Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study Lupus 10 480 483 11480845 10.1191/096120301678416033 1:CAS:528:DC%2BD3MXlvVKis78%3D (Pubitemid 32675047)
    • (2001) Lupus , vol.10 , Issue.7 , pp. 480-483
    • Remer, C.F.1    Weisman, M.H.2    Wallace, D.J.3
  • 12
    • 33144490424 scopus 로고    scopus 로고
    • Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: An open label trial [7]
    • DOI 10.1136/ard.2005.044248
    • LS Tam EK Li CK Wong CW Lam WC Li CC Szeto 2006 Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial Ann Rheum Dis 65 3 417 418 16474039 10.1136/ard.2005.044248 (Pubitemid 43268242)
    • (2006) Annals of the Rheumatic Diseases , vol.65 , Issue.3 , pp. 417-418
    • Tam, L.-S.1    Li, E.K.2    Wong, C.-K.3    Lam, C.W.K.4    Li, W.-C.5    Szeto, C.-C.6
  • 14
    • 11344278019 scopus 로고    scopus 로고
    • Lupus erythematosus with leflunomide: Induction or reactivation?
    • DOI 10.1136/ard.2003.019323
    • D Gensburger M Kawashima H Marotte J Kanitakis P Miossec 2005 Lupus erythematosus with leflunomide: induction or reactivation? Ann Rheum Dis 64 1 153 155 15608317 10.1136/ard.2003.019323 1:STN:280:DC%2BD2cnjtV2qsg%3D%3D (Pubitemid 40075297)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.1 , pp. 153-155
    • Gensburger, D.1    Kawashima, M.2    Marotte, H.3    Kanitakis, J.4    Miossec, P.5
  • 15
    • 67651230875 scopus 로고    scopus 로고
    • Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis
    • 19605743 10.1136/ard.2008.099093 1:CAS:528:DC%2BD1MXhtFGqsrjP
    • PB Grabar B Rozman D Logar S Praprotnik V Dolzan 2009 Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis Ann Rheum Dis 68 8 1367 1368 19605743 10.1136/ard.2008.099093 1:CAS:528:DC%2BD1MXhtFGqsrjP
    • (2009) Ann Rheum Dis , vol.68 , Issue.8 , pp. 1367-1368
    • Grabar, P.B.1    Rozman, B.2    Logar, D.3    Praprotnik, S.4    Dolzan, V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.